![](/img/cover-not-exists.png)
Rational engineering of a novel complement regulator-based therapeutic affords triple targeting of host surfaces and pathway-specific inhibition of complement activation
Christoph Q. Schmidt, Hongjun Bai, Zhuoer Lin, Antonio M. Risitano, Paul N. Barlow, Daniel Ricklin, John D. LambrisVolume:
217
Year:
2012
Language:
english
DOI:
10.1016/j.imbio.2012.08.195
File:
PDF, 67 KB
english, 2012